Khronicheskiy zapor: taktika vedeniya na osnove nauchnykh faktov


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Despite the continuous development of pharmacotherapy and a variety of approaches, chronic constipation remains difficult to treat disease. Today, under the existing approach in terms of evidence-based medicine, the consistent and graded use of dietary fibers, lactulose, polyethyleneglycol, and prucalopride is most justified. Lifestyle modification has no significant effect on the change in the frequency and nature of stool in patients with chronic constipation. Due to the lack of standardization, potential of biofeedback therapy and other rehabilitative treatment methods are not fully used. The surgical treatment of chronic constipation is relevant only in the case of clear indications, with failure of entire arsenal of therapeutic modalities (rehabilitative treatment) and pharmacotherapy.

Full Text

Restricted Access

About the authors

E. A Maevskaya

Email: evgenia.maevsckaja@yandex.ru

References

  1. Belsey J., Greenfield S., Candy D., et al. Systematic review: impact of constipation on quality of life in adults and children. Aliment Pharmacol Ther. 2010; 31: 938-49.
  2. Pinto-Sanchez M.I., Bercik P. Epidemiology and burden of chronic constipation. Can. J. Gastroenterol. 2011; 25: 11B-15B.
  3. Suares N.C., Ford A.C. Prevalence of, and risk factors for, chronicidiopathic constipation in the community: systematic review and meta-analysis. Am. J. Gastroenterol. 2011 ; 106: 1582-91.
  4. Wald A., Scarpignato C., Mueller-Lissner S., et al. A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation. Aliment Pharmacol. Ther. 2008; 28: 917-30.
  5. Wald A., Mueller-Lissner S., Kamm M.A., et al. Survey of laxative use by adults with self-defined constipation in South America and Asia: a comparison of six countries. Aliment Pharmacol. Ther. 2010; 31: 274-84.
  6. Higgins P.D.R., Johanson J.E. Epidemiology of constipation in North America: A systematic review. Am. J. Gastroenterol. 2004; 99: 750-59.
  7. Brandt L.J., Prather C.M., Quigley E.M., et al. Systematic review on the management of chronic constipation in North America. Am. J. Gastroenterol. 2005; 100: S5-S22.
  8. Маев И.В., Самсонов А.А., Дичева Д.Т., Андреев Д.Н. Обстипационный синдром. Медицинский вестник МВД. 2012; 4: 42-5.
  9. Fosnes G.S., Lydersen S., Farup P.G. Drugs and constipation in elderly in nursing homes: what is the relation? Gastroenterol. Res. Pract. 2012; 2012: 290-91.
  10. Rao S. Update on the management of constipation in the elderly: new treatment options. Clin. Interv. Aging. 2010; 5: 163-71.
  11. Eoff J.C., Lembo A.J. Optimal treatment of chronic constipation in managed care: review and roundtable discussion. J. Manag. Care Pharm. 2008; 14: 1-15.
  12. Lacy B.E., Levenick J.M., Crowell M. Chronic constipation: new diagnostic and treatment approaches. Therap. Adv. Gastroenterol. 2012; 5(4): 233-47.
  13. Самсонов А.А., Кучерявый Ю.А., Андреев Н.Г. Хронический запор: проблемы терапии. Врач. 2011; 4: 24-9.
  14. Drossman D.A. The Functional Gastrointestinal Disorders and the Rome III Process. Gastroenterology. 2006; 130: 1377-90.
  15. Locke G.III., Pemberton J., Philips S. American Gastroenterological Association Medical Position Statement: guidelaines on constipation. Gastroenterology. 2000; 119: 1761-66.
  16. American College of Gastroenterology Chronic Constipation Task Forse. An evidence-based approach to the management of chronic constipation in North America. Am. J. Gastroenterol. 2005; 100: S1-S4.
  17. Черемушкин С.В., Кучерявый Ю.А. Доказательная медицина и лечение хронического запора. Врач. 2012; 10: 42-7.
  18. Шептулин А.А. Прукалоприд в лечении хронических запоров функциональной природы. РЖГГК. 2012; 22(1): 9-13.
  19. Herz M.J., Kahan E., Zalevski S., et al. Constipation: a different entity for patients and doctors. Fam Pract. 1996; 13: 156-59.
  20. Gwee K.A., Ghoshal U.C., Gonlachanvit S., et al. Primary Care Management of Chronic Constipation in Asia: The ANMA Chronic Constipation Tool. J. Neurogastroenterol. Motil. 2013; 19(2): 149-60.
  21. Gonzalez-Martinez M.A., Ortiz-Olvera N.X., Mendez-Navarro J. Novel pharmacological therapies for management of chronic constipation. J. Clin. Gastroenterol. 2014; 48(1): 21-8.
  22. Pare P., Ferrazzi S., Thompson W.G., et al. An epidemiological survey of constipation in Canada: definitions, rates, demographics, and predictors of health care seeking. Am. J. Gastroenterol. 2001; 96: 3130-37.
  23. Remes-Troche J.M., Carmona-Sánchez R., González-Gutiérrez M., et al. What people mean by constipation? A general population based-study. Rev. Gastroenterol. Mex. 2009; 74: 321-28.
  24. Schiller L.R., Dennis E., Toth G. Primary care physicians consider constipation as a severe and bothersome medical condition that negatively impacts patients lives. Am. J. Gastroenterol. 2004; 99: S234-35.
  25. Johanson J.F., Kralstein J. Chronic constipation: a survey of the patient perspective. Aliment Pharmacol Ther. 2007; 25: 599-608.
  26. Gwee K.A., Pratap N., Chen M., et al. Patients with chronic constipation attending outpatient clinics in India and China may present as functional dyspepsia and receive inappropriate treatment. Neurogastroenterol. Motil. 2012; 24(suppl 2): 114.
  27. Kuo B., Maneerattanaporn M., Lee A.A., et al. Generalized transit delay on wireless motility capsule testing in patients with clinical suspicion of gastroparesis, small intestinal dysmotility, or slow transit constipation. Dig. Dis. Sci. 2011; 56(10): 2928-38.
  28. Черемушкин С.В., Кучерявый Ю.А. Принципы лечения хронического запора. Мед. совет. 2012; 9: 52-7.
  29. Казюлин А.Н., Кучерявый Ю.А. Практические и клинические аспекты синдрома клинического запора. Методическое руководство для врачей. М., 2005.
  30. Whitehead W.E., Drinkwater D., Cheskin L.J., et al. Constipation in the elderly living at home. Definition, prevalence, and relationship to lifestyle and health status. J. Am. Geriatr. Soc. 1989; 37: 423-29.
  31. De Schryver A.M., Keulemans Y.C., Peters H.P., et al. Effects of regular physical activity on defecation pattern in middle-aged patients complaining of chronic constipation. Scand. J. Gastroenterol. 2005; 40: 422-29.
  32. Chung B.D., Parekh U., Sellin J.H. Effect of increased fluid intake on stool output in normal healthy volunteers. J. Clin. Gastroenterol. 1999; 28: 29-32.
  33. Muller-Lissner S.A., Kamm M.A., Scarpignato C., Wald A. Myths and misconceptions about chronic constipation. Am. J. Gastroenterol. 2005; 100: 232-42.
  34. Dukas L., Willett W.C., Giovannucci E.L. Association between physical activity, fiber intake, and other lifestyle variables and constipation in a study of women. Am. J. Gastroenterol. 2003; 98: 1790-96.
  35. Murakami K., Sasaki S., Okubo H., et al. Association between dietary fiber, water and magnesium intake and functional constipation among young Japanese women. Eur. J. Clin. Nutr. 2007; 61: 616-22.
  36. Muller-Lissner S.A., Kamm M.A., Scarpignato C., Wald A. Myths and misconceptions about chronic constipation. Am. J. Gastroenterol. 2005; 100: 232-42.
  37. Pare P. The approach to diagnosis and treatment of chronic constipation: suggestions for a general practitioner. Can. J. Gastroenterol. 2011; 25(Suppl B): 36B-40B.
  38. Bove A., Bellini M., Battaglia E., et al. Consensus statement AIGO/SICCR diagnosis and treatment of chronic constipation and obstructed defecation (part II: treatment). World J. Gastroenterol. 2012; 18: 4994-5013.
  39. Anti M., Pignataro G., Armuzzi A. et al. Water supplementation enhances the effect of highfiber diet on stool frequency and laxative consumption in adult patients with functional constipation. Hepatogastroenterology. 1998; 45: 727-32.
  40. Ashraf W., Park F., Lof J., Quigley E.M. Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation. Aliment Pharmacol. Ther 1995; 9: 639-47.
  41. Маев И.В., Кучерявый Ю.А., Черемушкин С.В. Эволюция представлений о синдроме раздраженного кишечника. Методическое пособие для врачей. М., 2013.
  42. Маев И.В., Ивашкина И.Ю., Кучерявый Ю.А., Оганесян Т.С. Диагностика и лечение синдрома избыточного бактериального роста в тонкой кишке. Экспериментальная и клиническая гастроэнтерология. 2011; 3: 125-29.
  43. Lee-Robichaud H., Thomas K., Morgan J., Nelson R.L. Lactulose versus polyethylene glycol for chronic constipation. Cochrane Database Syst. Rev. 2010; ( 7): CD0075 70.
  44. Gordon M., Naidoo K., Akobeng A.K., Thomas A.G. Cochrane Review: Osmotic and stimulant laxatives for the management of childhoodconstipation (Review). Evid Based Child Health. 2013; 8(1): 57-109.
  45. Черемушкин С., Кучерявый Ю., Гончаренко А. и соавт. Ретроспективная оценка эффекта последействия полиэтиленгликоля при лечении хронического запора. Врач. 2013; 3: 58-62.
  46. Mueller-Lissner S., Kamm M.A., Wald A., et al. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation. Am. J. Gastroenterol. 2010; 105: 897-903.
  47. Kamm M.A., Mueller-Lissner S., Wald A., et al. Oral bisacodyl is effective and well-tolerated in patients with chronic constipation. Clin. Gastroenterol. Hepatol. 2011; 9: 577-83.
  48. Ford A.C., Talley N.J. Laxatives for chronic constipation in adults. BMJ. 2012; 345: e6168.
  49. Маев И.В., Андреев Д.Н., Дичева Д.Т., Гуртовенко И.Ю. Риск длительного применения слабительных препаратов. Врач. 2014; 1: 26-30.
  50. Маев И.В., Самсонов А.А., Андреев Д.Н. Современный алгоритм ведения пациентов с синдромом хронического запора с позиций внедрения новых фармакологических препаратов. Фарматека. 2012; 13: 37-43.
  51. Camilleri M., Kerstens R, Rykx A., et al. A placebocontrolled trial of prucalopride for severe chronic constipation. N. Engl. J. Med. 2008; 358: 2344-54.
  52. Quigley E.M., Vandeplassche L., Kerstens R., et al. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation-a 12-week, randomized, double-blind, placebo-controlled study. Aliment Pharmacol. Ther. 2009; 29: 315-28.
  53. Маев И.В., Дичева Д.Т., Андреев Д.Н. Новые возможности лечения хронического запора. Врач. 2012; 3: 45-8.
  54. Chiarioni G., Whitehead W.E., Pezza V., et al. Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology. 2006; 130: 657-64.
  55. Heymen S., Scarlett Y., Jones K., et al. Randomized, controlled trial shows biofeedback to be superior to alternative treatments for patients with pelvic floor dyssynergia-type constipation. Dis. Colon. Rectum. 2007; 50: 428-41.
  56. Rao S.S., Seaton K., Miller M., et al. Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation. Clin. Gastroenterol. Hepatol. 2007; 5: 331-38.
  57. Hsiao K.C., Jao S.W., Wu C.C., et al. Hand-assisted laparoscopic total colectomy for slow transit constipation. Int. J. Colorectal. Dis. 2008; 23: 419-24.
  58. Arebi N., Kalli T., Howson W., et al. Systematic review of abdominal surgery for chronic idiopathic constipation. Colorectal. Dis. 2011; 13: 1335-43.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies